All blog posts
Total 44 results for
Showing 24 out of 44 results
15 六月 2023
Overview of EU and South African regulatory and competition law in the Pharma sector
14 四月 2023
European Commission announces plans for new Article 102 TFEU Guidelines and amends 2008 Guidance on enforcement priorities
24 三月 2023
Non-notifiable M&A deals can be reviewed under abuse of dominance rules: does heightened regulatory intervention in deal-making lie ahead?
23 十一月 2022
SANCTION IMPOSED BY THE SPANISH COMPETITION AUTHORITY ON A PHARMA COMPANY FOR MISUSING LITIGATION STRATEGIES REGARDING PATENTS
11 十月 2022
Update on the Teva Copaxone EU case. The EU Commission issues a Statement of Objections against Teva over alleged anti-competitive conduct consisting of misuse of divisional patents and a disparagement campaign against its closest competitor
27 六月 2022
Overview of EU and South African regulatory and competition law in the Pharma sector
25 四月 2022
Wide ranging reforms to UK competition and consumer protection regimes unveiled
21 四月 2022
HSF team publishes update on antitrust developments in APAC
23 七月 2021
UK government proposes wide ranging reforms to its competition and consumer protection regimes
04 三月 2021
First time EU Commission pursues case relating to divisional patent filing and litigation strategies
16 二月 2021
Excessive pricing: EU Commission accepts Aspen’s drug pricing commitments
27 一月 2021
Metal trader requests fast-track competition infringement claim against leading trade association
Showing 24 out of 44 results
View moreKey contacts
Kyriakos Fountoukakos
Managing Partner, Competition/Antitrust, Regulation and Trade, Brussels
Veronica Roberts
Partner, Head of Competition/Antitrust, Regulation and Trade, UK, London
Linda Evans
Managing Partner, Competition Regulation and Trade, Asia and Australia, Sydney
Adelaide Luke
Partner, Head of Competition, Asia, Hong Kong
Jean Meijer
Managing Partner, Johannesburg Office, Johannesburg
Kristien Geeurickx
Knowledge Counsel, London